Compound Detail
CHEMBL2375975
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2375975 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PIUKQSMOYIMGDG-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
524.6
MW (Da)
5.41
ALogP
8
HBA
2
HBD
101.5
PSA (Ų)
0.28
QED
2
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Bcr/Abl fusion protein CHEMBL2096618 | IC50 | 5.96 | 5.96 | 1110.4 | 1 |
| K562 CHEMBL385 | IC50 | 5.29 | 5.29 | 5150.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Bcr/Abl fusion protein | IC50 | = | 1110.42 | nM | 5.96 | Inhibition of Bcr-Abl kinase (unknown origin) after 30 mins by HTRF assay | 23538233 |
| K562 | IC50 | = | 5150.0 | nM | 5.29 | Antiproliferative activity against human K562 cells after 48 hrs by MTT assay | 23538233 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23538233 | 10.1016/j.bmc.2013.02.036 | Bcr/Abl fusion protein | 1 |
| 23538233 | 10.1016/j.bmc.2013.02.036 | K562 | 1 |
Data from ChEMBL 36 via Core Engine